Ensure Safe & Effective Peptide Drugs: Mastering GMP Compliance for Quality Control
Apr 11, 2024

Blog

Ensure Safe & Effective Peptide Drugs: Mastering GMP Compliance for Quality Control

Unlocking the Mystery of cGMP Peptides: Key Considerations for GMP Compliance in Peptide Drug Quality Control

Three Inventive Biomedical Applications for Synthetic Peptides
Jan 30, 2024

News

Three Inventive Biomedical Applications for Synthetic Peptides

Learn about the therapeutic versatility of synthetic peptides as amyloidogenic agents and hydrogel components and in targeting and helping overcome tumor barriers.

New High-throughput Platform to Expedite Shared Neoantigen-Based Cancer Immunotherapies
Nov 24, 2023

News

New High-throughput Platform to Expedite Shared Neoantigen-Based Cancer Immunotherapies

Genentech has developed a pipeline using various high-throughput and functional assays to identify novel shared neoepitope-MHC pair targets for cancer immunotherapies.

A New Strategy Evades Bacterial Resistance-Targeting Beta-Lactamases with Synthetic Peptides to Improve Antibiotic Performance
Oct 25, 2023

News

A New Strategy Evades Bacterial Resistance-Targeting Beta-Lactamases with Synthetic Peptides to Improve Antibiotic Performance

Scientists at the Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Belgium, have developed a new approach to inhibit beta-lactamases to boost antibiotic efficacy.

Leveraging Antimicrobial Peptides to Counter Bacterial Resistance
Feb 28, 2023

News

Leveraging Antimicrobial Peptides to Counter Bacterial Resistance

The emergence of bacterial antibiotic resistance against limited therapeutic options is prompting research into the discovery and optimization of alternative therapies such as cyclic antimicrobial peptides.

Empowering Dendritic Cells for Improved Oncotherapy
Jan 31, 2023

News

Empowering Dendritic Cells for Improved Oncotherapy

Scientists at the Tisch Cancer Institute developed an immunotherapy based on intra-tumor administration of Flt3L and the oncolytic Newcastle Disease Virus (NDV) to improve recruiting and activating dendritic cells.

Neoantigen Peptides for Personalized T Cell Immunotherapies in Brain Cancer
Feb 02, 2022

News

Neoantigen Peptides for Personalized T Cell Immunotherapies in Brain Cancer

Learn how investigators at George Washington University Cancer Center leveraged synthetic peptides to activate and amplify patient-derived T cells to generate specific T cell immunotherapies for medulloblastoma.

Uncovering Immunogenic Peptides of Clinical Significance in CRISPR/Cas9
Nov 17, 2021

Resource

Uncovering Immunogenic Peptides of Clinical Significance in CRISPR/Cas9

uncovering-immunogenic-peptides-of-clinical-significance-in-crispr-cas9

Antibody and CD8+ T Cell Responses: How the Delta Variant Evades Immunity?
Nov 03, 2021

Resource

Antibody and CD8+ T Cell Responses: How the Delta Variant Evades Immunity?

SARS-CoV-2 vaccines have reduced efficiency against variants of concern. Find out how antibody and T cell responses are affected by variant associated mutations.

Infection and Vaccine-Induced T cell Responses Confer SARS-CoV-2 Variant Protection
Jun 16, 2021

Resource

Infection and Vaccine-Induced T cell Responses Confer SARS-CoV-2 Variant Protection

Learn about how vaccine or infection-induced T cell responses against the original SARS-CoV-2 strain remain protective against new variants.

< 1 2 3 4 > Total Pages 4
feedback

Do you like the current new website?

Hate

Dislike

Neutral

Like

Love

*